Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
23 drugs across 15 manufacturers|22 Generic,1 Brand
The Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class contains 23 NDCs from 15 manufacturers (22 generic, 1 brand), at an average NADAC of $5.41 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
23
22G / 1B
Manufacturers
15
Avg $5.4085/unit
Avg 7d Change
-4.87%
Across 22 drugs with changes
7d Activity
of 23 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class?
The Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class contains 23 NDCs from 15 manufacturers — 22 generic and 1 brand product.
What is the average price of Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor drugs?
The average NADAC for the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class is $5.4085 per unit across 23 NDCs.
Is generic cheaper than brand in the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class?
The average generic NADAC in this class is $1.5035 per unit, versus $91.3192 for brand — generic is about 98% cheaper on average.
Which manufacturers make Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor drugs?
15 manufacturers make drugs in the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class. Ranked by number of NDCs, the largest are Major Pharmaceuticals (3), American Health Packaging (3), Ajanta Pharma USA Inc. (2), Camber Pharmaceuticals Inc. (2), Strides Pharma Inc. (2).
How has Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor pricing changed recently?
Over the past 7 days, 11 NDCs in this class rose and 11 fell, with a class-wide average change of -4.9%.
Manufacturer Breakdown
15 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 3 more manufacturers